The nonavalent vaccine: a review of high-risk HPVs and a plea to the CDC
{{output}}
Two of the leading strategies to prevent cervical cancer are prophylactic human papillomavirus (HPV) vaccination and routine Papanicolaou (Pap) testing. However, regardless of being vaccinated with first-generation (bivalent and quadrivalent) HPV vaccines at t... ...
